Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy
Liu, Ruyu, Guo, Jiang, Lu, Yao, Zhang, Lu, Shen, Ge, Wu, Shuling, Chang, Mi, Hu, Leiping, Hao, Hongxiao, Li, Minghui, Xie, YaoLanguage:
english
Journal:
Clinical and Experimental Medicine
DOI:
10.1007/s10238-019-00560-z
Date:
May, 2019
File:
PDF, 808 KB
english, 2019